MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Search

ResMed Inc

Fechado

SetorSaúde

251.89 0.41

Visão Geral

Variação de preço das ações

24h

Atual

Mín

251.23

Máximo

252.59

Indicadores-chave

By Trading Economics

Rendimento

-31M

349M

Vendas

-12M

1.3B

P/E

Médio do Setor

25.114

87.826

Rendimento de Dividendos

0.89

Margem de lucro

26.096

Funcionários

10,600

EBITDA

-29M

503M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+16.47% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.89%

2.26%

Próximos Ganhos

29 de jan. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

12 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-2B

36B

Abertura anterior

251.48

Fecho anterior

251.89

Sentimento de Notícias

By Acuity

22%

78%

52 / 370 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de jan. de 2026, 00:16 UTC

Aquisições, Fusões, Aquisições de Empresas

Edwards Lifesciences Drops Merger With JenaValve

10 de jan. de 2026, 12:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Copper Is the Prize in Mining Megadeals -- WSJ

10 de jan. de 2026, 09:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

10 de jan. de 2026, 09:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

10 de jan. de 2026, 09:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

10 de jan. de 2026, 09:00 UTC

Ganhos

Big Banks Expected to Post Higher Profits as Shares Surge -- Barrons.com

9 de jan. de 2026, 22:18 UTC

Conversa de Mercado

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

9 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

9 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

9 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

9 de jan. de 2026, 21:43 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9 de jan. de 2026, 20:39 UTC

Conversa de Mercado

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9 de jan. de 2026, 20:38 UTC

Conversa de Mercado

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9 de jan. de 2026, 20:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9 de jan. de 2026, 20:30 UTC

Conversa de Mercado

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9 de jan. de 2026, 20:15 UTC

Conversa de Mercado

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9 de jan. de 2026, 20:07 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

9 de jan. de 2026, 20:07 UTC

Conversa de Mercado

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9 de jan. de 2026, 19:58 UTC

Aquisições, Fusões, Aquisições de Empresas

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9 de jan. de 2026, 19:42 UTC

Conversa de Mercado

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9 de jan. de 2026, 19:38 UTC

Aquisições, Fusões, Aquisições de Empresas

Wolters Kluwer Acquires StandardFusion >WTKWY

9 de jan. de 2026, 19:31 UTC

Ganhos

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9 de jan. de 2026, 19:28 UTC

Ganhos

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9 de jan. de 2026, 18:30 UTC

Conversa de Mercado

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9 de jan. de 2026, 18:23 UTC

Conversa de Mercado

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9 de jan. de 2026, 17:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

9 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

9 de jan. de 2026, 17:19 UTC

Conversa de Mercado

Energy Prices Not Seen Supporting More Drilling -- Market Talk

9 de jan. de 2026, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

16.47% parte superior

Previsão para 12 meses

Média 292.25 USD  16.47%

Máximo 345 USD

Mínimo 260 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

12 ratings

6

Comprar

6

Manter

0

Vender

Sentimento

By Acuity

52 / 370 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat